USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medical Innovation Developpement

USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, active 2017–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

13.7

Avg claims per patent

+150%

5-year filing velocity

The verdict

Medical holds 7 US patents across 5 technology areas, rank #36,362 of 50,000 tracked assignees.

#36,362
of 50,000 US assignees by volume: Top 84%
by Innovation Score (25.0/100): 13.7
avg claims per patent: +150%
filing velocity, last 5 yrs

Portfolio overview

Medical Innovation Developpement has been granted 7 US utility patents between 2017 and 2023, placing Medical Innovation Developpement at rank #36,362 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.7 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, Medical Innovation Developpement is one of the more focused assignees in the PatentsView dataset. By volume, Medical sits between MDB SRL (7 patents, rank #36,358) and Medigen, Inc. (7 patents, rank #36,366) - the closest US assignees by grant volume. The composite Innovation Score of 25.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 5 grants, compared with 2 in the 2015–2019 window, a +150% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Medical Innovation Developpement's 13.7 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Medical Innovation Developpement against peers pursuing similar technology classes.

MDB SRL

7
MDS Global Holding

7
Medal

7
Medeor Therapeuti…

7
Medical Intellige…

7
Medichem

7
Medicom Innovatio…

7
Medigen

7
Medical Innovatio… ◀

7

What this shows Medical holds 7 patents at rank #36,362, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Medical

By rank, the assignees closest to #36,362 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Medical's primary technology class.

Medical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

25 Top 84% higher than 16% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Medical Innovation Developpement patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	2	28.6%
2020	3	42.9%
2021	1	14.3%
2023	1	14.3%

Which technologies does Medical Innovation Developpement patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 4

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 3

B29C - SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING 1

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 1

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1

Top 5 of 5 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Focused

Claim Depth Standard

Velocity Accelerating

Where it ranks

Overall rank by patents

#36,362

Across all tracked assignees

Innovation Score

25.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Medical Innovation Developpement hold?

Medical Innovation Developpement holds 7 US granted patents filed between 2017 and 2023, spanning 5 technology areas.

What is Medical Innovation Developpement's Innovation Score?

Medical Innovation Developpement has an Innovation Score of 25.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Medical Innovation Developpement focus on?

Medical Innovation Developpement's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 4 patents. The company has filed patents in 5 CPC subclasses total.

Is Medical Innovation Developpement's patent filing rate increasing or decreasing?

Medical Innovation Developpement's recent filing velocity is +150% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Medical Innovation Developpement's patents?

Medical Innovation Developpement's patents average 13.7 claims each. This falls within the standard range, providing solid legal coverage.

How is the Medical Innovation Developpement patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Medical's 7 grants land it in the top 84% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Medical ranks #36,362 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.